TRIVARX LTD - Announcements

0.00%

1.1¢

Market Cap $6.818M

Healthcare Biotechnology

TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology... TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

TRI	MEB Appoints R&CPMK As Communications Agency in the US	PRICE SENSITIVE	25/06/21	191.45KB	Share
TRI	Section 708A Cleansing Notice and Appendix 2A		18/05/21	358.9KB	Share
TRI	Medibio strengthens its IP protection	PRICE SENSITIVE	04/05/21	138.49KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	30/04/21	397.8KB	Share
TRI	Re-submission of FDA 510(k) application	PRICE SENSITIVE	29/04/21	159.75KB	Share
TRI	Consumer Mental Health App Development - Second Test Phase	PRICE SENSITIVE	22/04/21	167.63KB	Share
TRI	Appendix 3G		15/04/21	272.26KB	Share
TRI	Appendix 2A		08/04/21	288.49KB	Share
TRI	Appendix 2A		08/04/21	288.59KB	Share
TRI	Appendix 2A		08/04/21	283.48KB	Share
TRI	Appendix 2A		08/04/21	283.4KB	Share
TRI	Section 708A Cleansing Notice and Appendix 2A		08/04/21	364.41KB	Share
TRI	Appendix 2A		08/04/21	309.62KB	Share
TRI	Proposed issue of Securities - MEB (Revised)		31/03/21	416.52KB	Share
TRI	MEB Share Purchase Plan Closes Strongly Oversubscribed	PRICE SENSITIVE	31/03/21	181.59KB	Share
TRI	Supplementary Prospectus	PRICE SENSITIVE	31/03/21	184.81KB	Share
TRI	Results of General Meeting		24/03/21	272.14KB	Share
TRI	Annual General Meeting - Venue		23/03/21	188.61KB	Share
TRI	MEB Begins Implementation of ilumen In the United Kingdom	PRICE SENSITIVE	19/03/21	220.5KB	Share
TRI	Medibio To Present at World Forum for Sleep Medicine		03/03/21	227.89KB	Share
TRI	SPP Offer Opens		26/02/21	226.38KB	Share
TRI	Share Purchase Plan Prospectus	PRICE SENSITIVE	26/02/21	860.18KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/21	582.16KB	Share
TRI	Notice of General Meeting/Proxy Form		23/02/21	624.92KB	Share
TRI	Change in substantial holding		18/02/21	174.11KB	Share
TRI	Appendix 3G		15/02/21	271.25KB	Share
TRI	Appendix 3G		15/02/21	267.97KB	Share
TRI	Section 708A Cleansing Notice and Appendix 2A		15/02/21	364.96KB	Share
TRI	Proposed issue of Securities - MEB (Revised)		15/02/21	343.74KB	Share
TRI	Underwritten Share Purchase Plan Update	PRICE SENSITIVE	15/02/21	167.32KB	Share
TRI	Investor Presentation		10/02/21	1.78MB	Share
TRI	Proposed issue of Securities - MEB		10/02/21	398.83KB	Share
TRI	Proposed issue of Securities - MEB		10/02/21	30.89KB	Share
TRI	Proposed issue of Securities - MEB		10/02/21	27.6KB	Share
TRI	MEB to Raise up to $3.5m By Way of a Placement and SPP	PRICE SENSITIVE	10/02/21	260.39KB	Share
TRI	Trading Halt	PRICE SENSITIVE	05/02/21	195.53KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	29/01/21	433.04KB	Share
TRI	Medibio Granted CE Mark Approval for MEBsleep	PRICE SENSITIVE	19/01/21	106.21KB	Share
TRI	Consumer Mental Health App Initial testing phase commenced	PRICE SENSITIVE	11/01/21	106.75KB	Share
TRI	US FDA advises further data needed for MEBsleep approval	PRICE SENSITIVE	29/12/20	188.85KB	Share
TRI	Updated Capital Structure		23/12/20	103.88KB	Share
TRI	Change of Director's Interest Notice		11/12/20	196.5KB	Share
TRI	Appendix 3G		08/12/20	138.49KB	Share
TRI	Appendix 3G		08/12/20	140.97KB	Share
TRI	Release of Securities from Escrow		03/12/20	103.22KB	Share
TRI	Update on Breakthrough Device Program	PRICE SENSITIVE	03/12/20	108.09KB	Share
TRI	Global Master License & Services Agreement with Compass	PRICE SENSITIVE	23/11/20	196.92KB	Share
TRI	Medibio Investor Webinar Presentation		19/11/20	1.48MB	Share
TRI	Constitution		13/11/20	368.9KB	Share
TRI	Results of Annual General Meeting		12/11/20	159.04KB	Share
TRI	AGM Presentation	PRICE SENSITIVE	12/11/20	1.19MB	Share
TRI	Chairman's Address to the 2020 Annual General Meeting		12/11/20	237.9KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	29/10/20	225.26KB	Share
TRI	Updated Capital Structure		27/10/20	103.74KB	Share
TRI	Revised Securities Trading Policy		15/10/20	391.39KB	Share
TRI	Appendix 3G		09/10/20	139.03KB	Share
TRI	Notice of Annual General Meeting/Proxy Form		09/10/20	588.47KB	Share
TRI	MEB Signs Clinical Trial Agreement with MedBridge Healthcare	PRICE SENSITIVE	07/10/20	231.79KB	Share
TRI	Request For FDA Breakthrough Device Designation Submitted	PRICE SENSITIVE	02/10/20	142.79KB	Share
TRI	2020 Annual Report		25/09/20	708.64KB	Share
TRI	Appendix 4G and Corporate Governance Statement		25/09/20	428.79KB	Share
TRI	FDA Strategy and Regulatory Update	PRICE SENSITIVE	31/08/20	189.16KB	Share
TRI	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	28/08/20	336.33KB	Share
TRI	Appendix 2A		26/08/20	269.91KB	Share
TRI	Patent Granted to Monitor Stress Conditions Using Heartrate	PRICE SENSITIVE	10/08/20	177.71KB	Share
TRI	FDA Strategy and Regulatory Update	PRICE SENSITIVE	07/08/20	193.82KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	30/07/20	453.75KB	Share
TRI	Change of Director's Interest Notice		15/07/20	157.18KB	Share
TRI	Appendix 2A		13/07/20	271.69KB	Share
TRI	Entitlement Issue Results	PRICE SENSITIVE	09/07/20	142.68KB	Share
TRI	Extension of Entitlement Offer		24/06/20	122.12KB	Share
TRI	Despatch of Offer Letter to Eligible Shareholders		18/06/20	298.7KB	Share
TRI	Appendix 3G		18/06/20	151.11KB	Share
TRI	Section 708A Cleansing Notice and Appendix 2A		18/06/20	247.09KB	Share
TRI	Letter to Ineligible Shareholder - Entitlement Offer		11/06/20	144.36KB	Share
TRI	Letter to Optionholders - Entitlement Offer		11/06/20	190.06KB	Share
TRI	Letter to Eligible Shareholder - Entitlement Offer		11/06/20	201.57KB	Share
TRI	Cleansing Notice		10/06/20	76.43KB	Share
TRI	Section 708AA(2)(F) Cleansing Statement		10/06/20	215.64KB	Share
TRI	Entitlement Offer Booklet	PRICE SENSITIVE	10/06/20	605.3KB	Share
TRI	Investor Presentation		10/06/20	1.3MB	Share
TRI	Proposed issue of Securities - MEB		10/06/20	41.14KB	Share
TRI	Placement and Fully Underwritten Entitlement Offer	PRICE SENSITIVE	10/06/20	166.07KB	Share
TRI	Trading Halt	PRICE SENSITIVE	05/06/20	205.31KB	Share
TRI	Appendix 2A		02/06/20	165.95KB	Share
TRI	Appendix 3G		02/06/20	272.61KB	Share
TRI	Appendix 2A		02/06/20	270.49KB	Share
TRI	Proposed issue of Securities - MEB		27/05/20	27.93KB	Share
TRI	Medibio Settles Joint Venture Dispute		27/05/20	229.72KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	30/04/20	456.23KB	Share
TRI	Medibio submits FDA 510K Application to FDA	PRICE SENSITIVE	30/04/20	240.89KB	Share
TRI	Capital Structure Update		16/04/20	181.21KB	Share
TRI	Final Compass Pilot Completed Successfully	PRICE SENSITIVE	09/04/20	227.02KB	Share
TRI	ilumen supporting global workforce during COVID-19 crisis		06/04/20	222.37KB	Share
TRI	MEB Signs MOU with DXC for ilumen		25/03/20	201.13KB	Share
TRI	FDA Strategy Update		19/03/20	170.46KB	Share
TRI	Executive Appointments at MEB to Support Growth of ilumen		09/03/20	225.01KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/20	792.58KB	Share
TRI	MEB signs Annual Services Agreement with Stantec Australia		27/02/20	176.11KB	Share
TRI	Strategic Plan for FDA and CE Mark Approval	PRICE SENSITIVE	14/02/20	192.36KB	Share

TRI MEB Appoints R&CPMK As Communications Agency in the US
25/06/21	PRICE SENSITIVE	191.45KB	Share
TRI Section 708A Cleansing Notice and Appendix 2A
18/05/21		358.9KB	Share
TRI Medibio strengthens its IP protection
04/05/21	PRICE SENSITIVE	138.49KB	Share
TRI Medibio Quarterly Update and Cashflow Report
30/04/21	PRICE SENSITIVE	397.8KB	Share
TRI Re-submission of FDA 510(k) application
29/04/21	PRICE SENSITIVE	159.75KB	Share
TRI Consumer Mental Health App Development - Second Test Phase
22/04/21	PRICE SENSITIVE	167.63KB	Share
TRI Appendix 3G
15/04/21		272.26KB	Share
TRI Appendix 2A
08/04/21		288.49KB	Share
TRI Appendix 2A
08/04/21		288.59KB	Share
TRI Appendix 2A
08/04/21		283.48KB	Share
TRI Appendix 2A
08/04/21		283.4KB	Share
TRI Section 708A Cleansing Notice and Appendix 2A
08/04/21		364.41KB	Share
TRI Appendix 2A
08/04/21		309.62KB	Share
TRI Proposed issue of Securities - MEB (Revised)
31/03/21		416.52KB	Share
TRI MEB Share Purchase Plan Closes Strongly Oversubscribed
31/03/21	PRICE SENSITIVE	181.59KB	Share
TRI Supplementary Prospectus
31/03/21	PRICE SENSITIVE	184.81KB	Share
TRI Results of General Meeting
24/03/21		272.14KB	Share
TRI Annual General Meeting - Venue
23/03/21		188.61KB	Share
TRI MEB Begins Implementation of ilumen In the United Kingdom
19/03/21	PRICE SENSITIVE	220.5KB	Share
TRI Medibio To Present at World Forum for Sleep Medicine
03/03/21		227.89KB	Share
TRI SPP Offer Opens
26/02/21		226.38KB	Share
TRI Share Purchase Plan Prospectus
26/02/21	PRICE SENSITIVE	860.18KB	Share
TRI Half Yearly Report and Accounts
24/02/21	PRICE SENSITIVE	582.16KB	Share
TRI Notice of General Meeting/Proxy Form
23/02/21		624.92KB	Share
TRI Change in substantial holding
18/02/21		174.11KB	Share
TRI Appendix 3G
15/02/21		271.25KB	Share
TRI Appendix 3G
15/02/21		267.97KB	Share
TRI Section 708A Cleansing Notice and Appendix 2A
15/02/21		364.96KB	Share
TRI Proposed issue of Securities - MEB (Revised)
15/02/21		343.74KB	Share
TRI Underwritten Share Purchase Plan Update
15/02/21	PRICE SENSITIVE	167.32KB	Share
TRI Investor Presentation
10/02/21		1.78MB	Share
TRI Proposed issue of Securities - MEB
10/02/21		398.83KB	Share
TRI Proposed issue of Securities - MEB
10/02/21		30.89KB	Share
TRI Proposed issue of Securities - MEB
10/02/21		27.6KB	Share
TRI MEB to Raise up to $3.5m By Way of a Placement and SPP
10/02/21	PRICE SENSITIVE	260.39KB	Share
TRI Trading Halt
05/02/21	PRICE SENSITIVE	195.53KB	Share
TRI Medibio Quarterly Update and Cashflow Report
29/01/21	PRICE SENSITIVE	433.04KB	Share
TRI Medibio Granted CE Mark Approval for MEBsleep
19/01/21	PRICE SENSITIVE	106.21KB	Share
TRI Consumer Mental Health App Initial testing phase commenced
11/01/21	PRICE SENSITIVE	106.75KB	Share
TRI US FDA advises further data needed for MEBsleep approval
29/12/20	PRICE SENSITIVE	188.85KB	Share
TRI Updated Capital Structure
23/12/20		103.88KB	Share
TRI Change of Director's Interest Notice
11/12/20		196.5KB	Share
TRI Appendix 3G
08/12/20		138.49KB	Share
TRI Appendix 3G
08/12/20		140.97KB	Share
TRI Release of Securities from Escrow
03/12/20		103.22KB	Share
TRI Update on Breakthrough Device Program
03/12/20	PRICE SENSITIVE	108.09KB	Share
TRI Global Master License & Services Agreement with Compass
23/11/20	PRICE SENSITIVE	196.92KB	Share
TRI Medibio Investor Webinar Presentation
19/11/20		1.48MB	Share
TRI Constitution
13/11/20		368.9KB	Share
TRI Results of Annual General Meeting
12/11/20		159.04KB	Share
TRI AGM Presentation
12/11/20	PRICE SENSITIVE	1.19MB	Share
TRI Chairman's Address to the 2020 Annual General Meeting
12/11/20		237.9KB	Share
TRI Medibio Quarterly Update and Cashflow Report
29/10/20	PRICE SENSITIVE	225.26KB	Share
TRI Updated Capital Structure
27/10/20		103.74KB	Share
TRI Revised Securities Trading Policy
15/10/20		391.39KB	Share
TRI Appendix 3G
09/10/20		139.03KB	Share
TRI Notice of Annual General Meeting/Proxy Form
09/10/20		588.47KB	Share
TRI MEB Signs Clinical Trial Agreement with MedBridge Healthcare
07/10/20	PRICE SENSITIVE	231.79KB	Share
TRI Request For FDA Breakthrough Device Designation Submitted
02/10/20	PRICE SENSITIVE	142.79KB	Share
TRI 2020 Annual Report
25/09/20		708.64KB	Share
TRI Appendix 4G and Corporate Governance Statement
25/09/20		428.79KB	Share
TRI FDA Strategy and Regulatory Update
31/08/20	PRICE SENSITIVE	189.16KB	Share
TRI Appendix 4E and Preliminary Final Report
28/08/20	PRICE SENSITIVE	336.33KB	Share
TRI Appendix 2A
26/08/20		269.91KB	Share
TRI Patent Granted to Monitor Stress Conditions Using Heartrate
10/08/20	PRICE SENSITIVE	177.71KB	Share
TRI FDA Strategy and Regulatory Update
07/08/20	PRICE SENSITIVE	193.82KB	Share
TRI Medibio Quarterly Update and Cashflow Report
30/07/20	PRICE SENSITIVE	453.75KB	Share
TRI Change of Director's Interest Notice
15/07/20		157.18KB	Share
TRI Appendix 2A
13/07/20		271.69KB	Share
TRI Entitlement Issue Results
09/07/20	PRICE SENSITIVE	142.68KB	Share
TRI Extension of Entitlement Offer
24/06/20		122.12KB	Share
TRI Despatch of Offer Letter to Eligible Shareholders
18/06/20		298.7KB	Share
TRI Appendix 3G
18/06/20		151.11KB	Share
TRI Section 708A Cleansing Notice and Appendix 2A
18/06/20		247.09KB	Share
TRI Letter to Ineligible Shareholder - Entitlement Offer
11/06/20		144.36KB	Share
TRI Letter to Optionholders - Entitlement Offer
11/06/20		190.06KB	Share
TRI Letter to Eligible Shareholder - Entitlement Offer
11/06/20		201.57KB	Share
TRI Cleansing Notice
10/06/20		76.43KB	Share
TRI Section 708AA(2)(F) Cleansing Statement
10/06/20		215.64KB	Share
TRI Entitlement Offer Booklet
10/06/20	PRICE SENSITIVE	605.3KB	Share
TRI Investor Presentation
10/06/20		1.3MB	Share
TRI Proposed issue of Securities - MEB
10/06/20		41.14KB	Share
TRI Placement and Fully Underwritten Entitlement Offer
10/06/20	PRICE SENSITIVE	166.07KB	Share
TRI Trading Halt
05/06/20	PRICE SENSITIVE	205.31KB	Share
TRI Appendix 2A
02/06/20		165.95KB	Share
TRI Appendix 3G
02/06/20		272.61KB	Share
TRI Appendix 2A
02/06/20		270.49KB	Share
TRI Proposed issue of Securities - MEB
27/05/20		27.93KB	Share
TRI Medibio Settles Joint Venture Dispute
27/05/20		229.72KB	Share
TRI Medibio Quarterly Update and Cashflow Report
30/04/20	PRICE SENSITIVE	456.23KB	Share
TRI Medibio submits FDA 510K Application to FDA
30/04/20	PRICE SENSITIVE	240.89KB	Share
TRI Capital Structure Update
16/04/20		181.21KB	Share
TRI Final Compass Pilot Completed Successfully
09/04/20	PRICE SENSITIVE	227.02KB	Share
TRI ilumen supporting global workforce during COVID-19 crisis
06/04/20		222.37KB	Share
TRI MEB Signs MOU with DXC for ilumen
25/03/20		201.13KB	Share
TRI FDA Strategy Update
19/03/20		170.46KB	Share
TRI Executive Appointments at MEB to Support Growth of ilumen
09/03/20		225.01KB	Share
TRI Half Yearly Report and Accounts
28/02/20	PRICE SENSITIVE	792.58KB	Share
TRI MEB signs Annual Services Agreement with Stantec Australia
27/02/20		176.11KB	Share
TRI Strategic Plan for FDA and CE Mark Approval
14/02/20	PRICE SENSITIVE	192.36KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $6.818M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.1¢	$7.732K	701.4K

Buyers (Bids)

No.	Vol.	Price($)
7	3030000	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	760913	2

View Market Depth

No.	Vol.	Price($)
7	3030000	0.010
8	6886324	0.009
15	3470750	0.008
2	271571	0.007
2	385000	0.006

Price($)	Vol.	No.
0.012	760913	2
0.013	1017587	3
0.014	871302	4
0.015	1195000	4
0.016	1027142	2

Last trade - 13.06pm 16/09/2025 (20 minute delay)

TRI (ASX) Chart

TRIVARX LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available